-
1
-
-
0025819780
-
Inhibition of extrinsic pathway inhibitor shortens the coagulation time of normal plasma and of hemophilia plasma
-
Nordfang O, Valentin S, Beck TC, Hedner U. Inhibition of extrinsic pathway inhibitor shortens the coagulation time of normal plasma and of hemophilia plasma. Thromb Haemost 1991;66(4):464-7.
-
(1991)
Thromb Haemost
, vol.66
, Issue.4
, pp. 464-467
-
-
Nordfang, O.1
Valentin, S.2
Beck, T.C.3
Hedner, U.4
-
2
-
-
0025986464
-
Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmas
-
Welsch DJ, Novotny WF, Wun TC. Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmas. Thromb Res 1991;64(2):213-22.
-
(1991)
Thromb Res
, vol.64
, Issue.2
, pp. 213-222
-
-
Welsch, D.J.1
Novotny, W.F.2
Wun, T.C.3
-
3
-
-
0029073453
-
Blocking of tissue factor pathway inhibitor (TFPI) shortens the bleeding time in rabbits with antibody induced haemophilia A
-
Erhardtsen E, Ezban M, Madsen MT, Diness V, Glazer S, Hedner U, et al. Blocking of tissue factor pathway inhibitor (TFPI) shortens the bleeding time in rabbits with antibody induced haemophilia A. Blood Coagul Fibrinolysis 1995;6(5):388-94.
-
(1995)
Blood Coagul Fibrinolysis
, vol.6
, Issue.5
, pp. 388-394
-
-
Erhardtsen, E.1
Ezban, M.2
Madsen, M.T.3
Diness, V.4
Glazer, S.5
Hedner, U.6
-
4
-
-
79951933686
-
First 20 years with recombinant FVIIa (NovoSeven)
-
Hedner U, Lee CA. First 20 years with recombinant FVIIa (NovoSeven). Haemophilia 2011;17(1):e172-82.
-
(2011)
Haemophilia
, vol.17
, Issue.1
-
-
Hedner, U.1
Lee, C.A.2
-
5
-
-
0032549024
-
Regulation of extrinsic pathway factor Xa formation by tissue factor pathway inhibitor
-
DOI 10.1074/jbc.273.8.4378
-
Baugh RJ, Broze GJ, Krishnaswamy S. Regulation of extrinsic pathway factor Xa formation by tissue factor pathway inhibitor. J Biol Chem 1998;273(8):4378-86. (Pubitemid 28103174)
-
(1998)
Journal of Biological Chemistry
, vol.273
, Issue.8
, pp. 4378-4386
-
-
Baugh, R.J.1
Broze Jr., G.J.2
Krishnaswamy, S.3
-
6
-
-
0030033356
-
Inhibitory properties of separate recombinant Kunitz-type-protease- inhibitor domains from tissue-factor-pathway inhibitor
-
Petersen LC, Bjorn SE, Olsen OH, Nordfang O, Norris F, Norris K. Inhibitory properties of separate recombinant Kunitz-type-protease-inhibitor domains from tissuefactor- pathway inhibitor. Eur J Biochem 1996;235(1-2):310-6. (Pubitemid 26048630)
-
(1996)
European Journal of Biochemistry
, vol.235
, Issue.1-2
, pp. 310-316
-
-
Petersen, L.C.1
Bjorn, S.E.2
Olsen, O.H.3
Nordfang, O.4
Norris, F.5
Norris, K.6
-
7
-
-
32244438720
-
Tissue factor pathway inhibitor: Structure, biology and involvement in disease
-
DOI 10.1002/path.1871
-
Lwaleed BA, Bass PS. Tissue factor pathway inhibitor: structure, biology and involvement in disease. J Pathol 2006;208(3):327-39. (Pubitemid 43210519)
-
(2006)
Journal of Pathology
, vol.208
, Issue.3
, pp. 327-339
-
-
Lwaleed, B.A.1
Bass, P.S.2
-
8
-
-
33645538085
-
Improved coagulation in bleeding disorders by Non-Anticoagulant Sulfated Polysaccharides (NASP)
-
Liu T, Scallan CD, Broze GJ, Patarroyo-White S, Pierce GF, Johnson KW. Improved coagulation in bleeding disorders by Non-Anticoagulant Sulfated Polysaccharides (NASP). Thromb Haemost 2006;95(1):68-76.
-
(2006)
Thromb Haemost
, vol.95
, Issue.1
, pp. 68-76
-
-
Liu, T.1
Scallan, C.D.2
Broze, G.J.3
Patarroyo-White, S.4
Pierce, G.F.5
Johnson, K.W.6
-
9
-
-
38349145384
-
Efficacy and safety of a new-class hemostatic drug candidate, AV513, in dogs with hemophilia A
-
Prasad S, Lillicrap D, Labelle A, Knappe S, Keller T, Burnett E, et al. Efficacy and safety of a new-class hemostatic drug candidate, AV513, in dogs with hemophilia A. Blood 2008;111(2):672-9.
-
(2008)
Blood
, vol.111
, Issue.2
, pp. 672-679
-
-
Prasad, S.1
Lillicrap, D.2
Labelle, A.3
Knappe, S.4
Keller, T.5
Burnett, E.6
-
10
-
-
79956299608
-
Aptamer ARC19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitor
-
Waters EK, Genga RM, Schwartz MC, Nelson JA, Schaub RG, Olson KA, et al. Aptamer ARC19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitor. Blood 2011;117(20):5514-22.
-
(2011)
Blood
, vol.117
, Issue.20
, pp. 5514-5522
-
-
Waters, E.K.1
Genga, R.M.2
Schwartz, M.C.3
Nelson, J.A.4
Schaub, R.G.5
Olson, K.A.6
-
11
-
-
80052415230
-
Improvement of spatial fibrin formation by the anti-TFPI aptamer BAX499: Changing clot size by targeting extrinsic pathway initiation
-
Parunov LA, Fadeeva OA, Balandina AN, Soshitova NP, Kopylov KG, Kumskova MA, et al. Improvement of spatial fibrin formation by the anti-TFPI aptamer BAX499: changing clot size by targeting extrinsic pathway initiation. J Thromb Haemost 2011;9(9):1825-34.
-
(2011)
J Thromb Haemost
, vol.9
, Issue.9
, pp. 1825-1834
-
-
Parunov, L.A.1
Fadeeva, O.A.2
Balandina, A.N.3
Soshitova, N.P.4
Kopylov, K.G.5
Kumskova, M.A.6
-
12
-
-
84859806411
-
-
ISTH abstracts, P-WE-126
-
Hoellriegl W, Dockal M, Schiviz A, Lawo JP, Verdino D, Leidenmuehler P, et al. Inhibition of TFPI efficiently improves hemostasis in hemophilic mice; 2011 (ISTH abstracts, P-WE-126).
-
(2011)
Inhibition of TFPI Efficiently Improves Hemostasis in Hemophilic Mice
-
-
Hoellriegl, W.1
Dockal, M.2
Schiviz, A.3
Lawo, J.P.4
Verdino, D.5
Leidenmuehler, P.6
-
13
-
-
84859806408
-
-
ISTH abstracts, P-MO-121
-
Lauritzen B, Hansen L, Agersoe H, Balling KW, Hermit MB, Clausen JT, et al. A monoclonal anti-TFPI-antibody, mAb 2021, is efficacious against bleeding in haemophilic rabbits for at least 7 days; 2011 (ISTH abstracts, P-MO-121).
-
(2011)
A Monoclonal Anti-TFPI-antibody, MAb 2021, Is Efficacious Against Bleeding in Haemophilic Rabbits for at Least 7 Days
-
-
Lauritzen, B.1
Hansen, L.2
Agersoe, H.3
Balling, K.W.4
Hermit, M.B.5
Clausen, J.T.6
-
14
-
-
0024991650
-
Regulation of coagulation by a multivalent Kunitz-type inhibitor
-
DOI 10.1021/bi00485a001
-
Broze GJ, Girard TJ, Novotny WF. Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry 1990;29(33):7539-46. (Pubitemid 20279168)
-
(1990)
Biochemistry
, vol.29
, Issue.33
, pp. 7539-7546
-
-
Broze Jr., G.J.1
Girard, T.J.2
Novotny, W.F.3
-
15
-
-
0026440727
-
Bacterial expression, purification, and partial characterization of amino acids 94-155 of human tissue factor pathway inhibitor (TFPI) as an inhibitor of blood coagulation factor Xa
-
Day KC, Welsch DJ. Bacterial expression, purification, and partial characterization of amino acids 94-155 of human tissue factor pathway inhibitor (TFPI) as an inhibitor of blood coagulation factor Xa. Thromb Res 1992;68(4-5):369-81.
-
(1992)
Thromb Res
, vol.68
, Issue.4-5
, pp. 369-381
-
-
Day, K.C.1
Welsch, D.J.2
-
16
-
-
0031566430
-
The second Kunitz domain of human tissue factor pathway inhibitor: Cloning, structure determination and interaction with factor Xa
-
DOI 10.1006/jmbi.1997.1029
-
Burgering MJ, Orbons LP, van-der D, Mulders J, Theunissen HJ, Grootenhuis PD, et al. The second Kunitz domain of human tissue factor pathway inhibitor: cloning, structure determination and interaction with factor Xa. J Mol Biol 1997;269(3):395-407. (Pubitemid 27267761)
-
(1997)
Journal of Molecular Biology
, vol.269
, Issue.3
, pp. 395-407
-
-
Burgering, M.J.M.1
Orbons, L.P.M.2
Van Der, D.A.3
Mulders, J.4
Theunissen, H.J.M.5
Grootenhuis, P.D.J.6
Bode, W.7
Huber, R.8
Stubbs, M.T.9
|